ropinirole has been researched along with Neurodegenerative Diseases in 2 studies
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dopamine receptor agonists provide sustained dopamin-ergic stimulation and have been found to delay the initiation of levodopa treatment and reduce the frequency of various motor complications due to the long-term use of levodopa." | 3.11 | Comparison of pramipexole versus ropinirole in the treatment of Parkinson's disease. ( Gencler, OS; Oztekin, MF; Oztekin, N, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gencler, OS | 1 |
| Oztekin, N | 1 |
| Oztekin, MF | 1 |
| Naz, F | 1 |
| Fatima, M | 1 |
| Naseem, S | 1 |
| Khan, W | 1 |
| Mondal, AC | 1 |
| Siddique, YH | 1 |
1 review available for ropinirole and Neurodegenerative Diseases
| Article | Year |
|---|---|
Ropinirole silver nanocomposite attenuates neurodegeneration in the transgenic Drosophila melanogaster model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Disease Models, Anima | 2020 |
1 trial available for ropinirole and Neurodegenerative Diseases
| Article | Year |
|---|---|
Comparison of pramipexole versus ropinirole in the treatment of Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Humans; Indoles; Middle Aged; Neurodegenerative Diseases; Parkinson | 2022 |